BACTEK-R Withdrawn Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Withdrawn | Prevention | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT04452643 | Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel |